IL6 and Alzheimer disease: These factors activate the nuclear factor-κB (NF-κB) pathway and stimulate interleukin (IL)-6 and interferon-γ secretions, subsequently triggering Aβ accumulation, tau hyperphosphorylation, and NFT deposition in AD (Gao et al. 2021; Han et al. 2020).